Salt Lake City-based Sera Prognostics announced that the American Medical Association (AMA) has assigned a new, dedicated Current Procedural Terminology (CPT) Proprietary Laboratory Analysis (PLA) code to facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention. The establishment of the new code, 0247U, is a result of the AMA’s PLA program, which enables labs with distinct, single-source Laboratory Developed Tests (LDT) to apply for a dedicated code that can be utilized to bill payors in order to receive reimbursement. This code is included in the revised set of PLA codes the AMA released on December 30, 2020, with an effective date of April 1, 2021.

新的代码0247U,与官方描述符相关,官方描述符,“产科(早产),胰岛素样生长因子结合蛋白4(IBP4),性激素结合球蛋白(SHBG),通过LC-MS进行定量测量/ MS,利用母体血清,结合临床资料,报告为自发性早产的预测风险分层。“因此,它是特定于预rm测试。

“该专用CPT解放军代码的收到是我们商业战略中建立编码,覆盖和支付的重要里程碑,为我们的专有预级别考试,塞马预测委员会主席和首席执行官MD Gregory C. Critchfield说。“我们认为Pretrm测试有一个重要的作用,以改善允许旨在减少不利结果的早期主动干预措施,从而降低医疗费用。我们致力于使测试广泛访问。这个CPT解放则是我们正在进行的努力,以确保从个人雇主赞助,商业和医疗补助保健计划,我们的业务和市场准入策略的重要组成部分获得报销。“

早产是新生儿疾病和死亡的主要原因。Prevrm测试为无症状,单身妊娠的自发早产提供了早期和个人风险预测。通过预级别识别更高的风险妊娠使资源能够更有效地专注于患有不良新生儿结果风险的妊娠。yabo体育苹果下载地址

有关更多信息,请访问血清预测